Medical technology company Masimo (MASI) has agreed to be acquired by Danaher Corporation (DHR) for $180 per share in cash, valuing the deal at approximately $9.9 billion. California-based Masimo's ...
Portable genome sequencers are revolutionizing genomic research. However, their reliance on external systems introduces new vulnerabilities that threaten the security of these sequencers. By employing ...
Rebecca McClay has 10+ years of experience writing and editing content. Rebecca is an expert in personal finance, business, and financial markets. She received her master's in business journalism from ...
Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
A comprehensive assessment of how transformation of dietary nutrients by the gut microbiota influences host health is needed. Systematic integration of 5,554 global gut metagenomes and various ...
Biotechnology company Abivax on Thursday dismissed a report by French media publication La Lettre saying it had granted AstraZeneca exclusive access to confidential information until March 23 to ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results